fda glp-1 compounding crackdown september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our September 15, 2025: Telehealth company
Description
The goal shouldn't be to lose weight it should be to lose fat while preserving (or building) muscle
Published: Issue date: DOI:
No credit card
An Analytical Study Based on Post-Marketing Approval Pharmacovigilance Data. Frontiers in Endocrinology, vol
Athletes using Ozempic may find that: Gels and sports drinks become intolerable Pre-run meals sit heavy for too long Hydration becomes more difficult, especially with added carbohydrates Gut distress increases, leading to poor performance and even DNF scenarios Because semaglutide delay gastric emptying, fuel may not be absorbed in time to meet energy demands during training or racing
